Analysts expect Vertex Pharmaceuticals Inc / Ma to report revenue of 3.60 B for Q3 26, against a range of 3.34 B to 3.86 B. The most recent reported quarter, Q2 26, came in at 3.33 B, a 7.5% beat against the 3.10 B consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 2.77 B | 2.91 B | 2.77 B | 2.94 B | 3.08 B | 3.19 B | 2.99 B | 3.33 B | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 2.68 B | 3.02 B | 2.97 B | 3.26 B | 3.25 B | 3.57 B | 3.09 B | 3.22 B | 3.86 B | 3.45 B | 3.59 B | 4.07 B | 4.24 B | 4.01 B | 4.15 B | 4.50 B | ||||||||||
| Low Estimate | 2.37 B | 2.66 B | 2.57 B | 2.95 B | 2.70 B | 3.11 B | 2.68 B | 2.98 B | 3.34 B | 3.21 B | 3.36 B | 3.55 B | 3.60 B | 3.40 B | 3.60 B | 3.92 B | ||||||||||
| Consensus Estimate | 2.53 B | 2.84 B | 2.77 B | 3.10 B | 2.98 B | 3.34 B | 2.89 B | 3.10 B | 3.60 B | 3.33 B | 3.47 B | 3.81 B | 3.92 B | 3.71 B | 3.87 B | 4.21 B |
Analysts expect Vertex Pharmaceuticals Inc / Ma to report earnings per share of 5.06 for Q3 26, against a range of 4.56 to 5.56. The most recent reported quarter, Q2 26, came in at 4.73, a 3.5% beat against the 4.57 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 4.38 | 3.98 | 4.06 | 4.52 | 4.80 | 5.03 | 4.47 | 4.73 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 4.01 | 4.65 | 4.84 | 4.89 | 4.85 | 5.89 | 4.17 | 4.88 | 5.56 | 4.74 | 4.83 | 5.46 | 5.35 | 5.92 | 6.03 | 7.00 | ||||||||||
| Low Estimate | 3.65 | 3.95 | 4.18 | 4.01 | 4.47 | 4.95 | 3.83 | 4.26 | 4.56 | 4.18 | 4.33 | 5.00 | 4.55 | 5.22 | 5.23 | 5.94 | ||||||||||
| Consensus Estimate | 3.83 | 4.30 | 4.51 | 4.45 | 4.66 | 5.42 | 4.00 | 4.57 | 5.06 | 4.46 | 4.58 | 5.23 | 4.95 | 5.57 | 5.63 | 6.47 |
Pull Wall Street consensus for Vertex Pharmaceuticals Inc / Ma (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=VRTX&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "VRTX", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=VRTX&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();